>
🏚
Home		 🚀
About		 📪
Contact
Update All
 		 
Random
 ✏️  Posts: 18,011
 
Update All
 
Random
Coronavirus
▶︎ TO SUBREDDIT
COVID19
▶︎ TO SUBREDDIT
COVID19_support  
▶︎ TO SUBREDDIT
China_flu
▶︎ TO SUBREDDIT
epidemic
▶︎ TO SUBREDDIT
Virology
▶︎ TO SUBREDDIT
ID_news
▶︎ TO SUBREDDIT
COVIDProjects
▶︎ TO SUBREDDIT
covidbigdata
▶︎ TO SUBREDDIT
 ✏️  Posts: 18,011

 385. COVID19 Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting
2024-11-19 04:46:07 EST Source
 
 386. COVID19 Cognitive impact and brain structural changes in long COVID patients: a cross-sectional MRI study two years post infection in a cohort from Argentina
2024-11-19 04:36:04 EST Source
 
 387. COVID19 Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study
2024-11-19 04:29:49 EST Source
 
 388. COVID19 Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19
2024-11-17 16:32:55 EST Source
 
 389. COVID19 IL-7 promotes mRNA vaccine-induced long-term immunity
2024-11-17 12:35:19 EST Source
 
 390. COVID19 Cardiovascular Magnetic Resonance Reveals Cardiac Inflammation and Fibrosis in Symptomatic Patients with Post-COVID-19 Syndrome: Findings from the INSPIRE-CMR Multicenter Study
2024-11-17 08:49:01 EST Source
 
 391. COVID19 In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza: a retrospective, nationwide cohort study in Switzerland
2024-11-15 01:43:35 EST Source
 
 392. COVID19 This Is Me, Anyone Else
2024-11-14 20:01:25 EST Source
 
 393. COVID19 SARS-CoV-2 evolution in the absence of selective immune pressures, results in antibody resistance, interferon suppression and phenotypic differences by lineage
2024-11-13 10:12:06 EST Source
 
 394. COVID19 A Mouse-adapted SARS-CoV-2 Model for Investigating Post-acute Sequelae of COVID infection
2024-11-11 23:16:41 EST Source
 
 395. COVID19 Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea
2024-11-11 15:24:01 EST Source
 
 396. COVID19 Impact of vaccination on SARS-CoV-2 evolution and immune escape variants
2024-11-11 11:44:27 EST Source
 
 397. COVID19 Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain
2024-11-11 09:12:36 EST Source
 
 398. COVID19 Temporal trajectories of long-COVID symptoms in adults with 22 months follow-up in a prospective cohort study in Norway
2024-11-11 08:32:52 EST Source
 
 399. COVID19 Precision phenotyping for curating research cohorts of patients with unexplained post-acute sequelae of COVID-19
2024-11-11 02:02:22 EST Source
 
 400. COVID19 Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study
2024-11-09 03:57:35 EST Source
 
 401. COVID19 Late olfactory bulb involvement in COVID19
2024-11-07 23:54:37 EST Source
 
 402. COVID19 COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses
2024-11-07 14:45:25 EST Source
 
 403. COVID19 Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study
2024-11-07 11:35:55 EST Source
 
 404. COVID19 Immunologic and Biophysical Features of the BNT162b2 JN.1- and KP.2-Adapted COVID-19 Vaccines
2024-11-07 02:52:17 EST Source
 
 405. COVID19 Factors associated with general practitioner-led diagnosis of long COVID: an observational study using electronic general practice data from Victoria and New South Wales, Australia
2024-11-04 20:49:24 EST Source
 
 406. COVID19 It was shrek’s fault
2024-11-03 22:48:46 EST Source
 
 407. COVID19 Monthly Scientific Discussion Thread - November 2024
2024-11-01 08:00:49 EST Source
 
 408. COVID19 Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study
2024-10-31 09:11:00 EST Source
 
 409. COVID19 Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function
2024-10-30 18:04:16 EST Source
 
 410. COVID19 COVID-19 No Longer the Leading Cause of Death from Infectious Diseases
2024-10-30 07:15:11 EST Source
 
 411. COVID19 Nirmatrelvir plus ritonavir reduces COVID-19 hospitalization and prevents long COVID in adult outpatients
2024-10-29 22:24:07 EST Source
 
 412. COVID19 Enhanced immune evasion of SARS-CoV-2 KP.3.1.1 and XEC through NTD glycosylation
2024-10-27 03:31:53 EST Source
 
 413. COVID19 Cough2COVID-19 detection using an enhanced multi layer ensemble deep learning framework and CoughFeatureRanker - Scientific Reports
2024-10-25 18:34:39 EST Source
 
 414. COVID19 Transmission of SARS-CoV-2 on aircraft: A scoping review
2024-10-24 10:56:57 EST Source
 
 415. COVID19 Did Covid really escape from a lab? [The Week mag]
2024-10-24 04:08:03 EST Source
 
 416. COVID19 FDA Approved Covid-19 Test Expiration Date Increase Information
2024-10-23 15:09:50 EST Source
 
 417. COVID19 Crises Narratives Defining the COVID-19 Pandemic: Expert Uncertainties and Conspiratorial Sensemaking
2024-10-22 06:07:48 EST Source
 
 418. COVID19 Trends in Pediatric Hospital Admissions Caused or Contributed by SARS-CoV-2 Infection in England
2024-10-21 09:25:33 EST Source
 
 419. COVID19 Efficacy of Air Cleaning Units for preventing SARS-CoV-2 and other hospital-acquired infections on medicine for older people wards: A quasi-experimental controlled before-and- after study
2024-10-21 01:51:09 EST Source
 
 420. COVID19 For Adults Presenting to the Emergency Department, Mortality Is 7.9% for COVID-19 (Omicron), 6.0% for RSV, and 2.5% for Influenza
2024-10-19 12:59:11 EST Source
 
 421. COVID19 Changes in thalamic functional connectivity in post-Covid patients with and without fatigue
2024-10-19 12:51:39 EST Source
 
 422. COVID19 Coronavirus M protein promotes mitophagy over virophagy by recruiting PDPK1 to phosphorylate SQSTM1 at T138
2024-10-17 10:01:38 EST Source
 
 423. COVID19 Systematic review and meta analysis of cross immunity and the smokers paradox in COVID19
2024-10-17 05:36:10 EST Source
 
 424. COVID19 Is COVID-19 Making a Comeback? FLiRT Variant Symptoms and the Bird Flu Outbreak of 2024
2024-10-16 15:00:13 EST Source
 
 425. COVID19 CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID
2024-10-15 14:33:59 EST Source
 
 426. COVID19 Long Covid is a significant health crisis in China too
2024-10-15 13:28:28 EST Source
 
 427. COVID19 Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants
2024-10-15 13:27:19 EST Source
 
 428. COVID19 SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients
2024-10-14 12:31:22 EST Source
 
 429. COVID19 Covid Conscious support group I founded. Its virtual.
2024-10-10 20:24:39 EST Source
 
 430. COVID19 Cognitive changes persist in volunteers infected with Covid-19 for at least one year
2024-10-10 09:14:31 EST Source
 
 431. COVID19 A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Completely Protective Multivalent Mucosal Dual Vaccine Against COVID-19 and Flu
2024-10-10 03:55:13 EST Source
 
 432. COVID19 SARS-CoV-2 antigen rapid detection tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccination
2024-10-09 20:10:25 EST Source
 
 433. COVID19 Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study
2024-10-09 16:24:27 EST Source
 
 434. COVID19 COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type
2024-10-09 09:26:21 EST Source
 
 435. COVID19 Mathematical simulation of COVID-19 infection risk factor in cardiovascular diabetic patients. The effect of metformin and the act of viral volume
2024-10-06 20:20:11 EST Source
 
 436. COVID19 Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
2024-10-06 13:37:16 EST Source
 
 437. COVID19 Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC
2024-10-05 05:16:18 EST Source
 
 438. COVID19 A novel SARS-CoV-2 recombinant transmitted from a patient with an acute co-infection
2024-10-03 08:11:19 EST Source
 
 439. COVID19 Eight-Week Creatine-Glucose Supplementation Alleviates Clinical Features of Long COVID
2024-10-02 03:54:39 EST Source
 
 440. COVID19 Effects of six-month creatine supplementation on patient- and clinician-reported outcomes, and tissue creatine levels in patients with post-COVID-19 fatigue syndrome
2024-10-02 03:51:45 EST Source
 
 441. COVID19 Monthly Scientific Discussion Thread - October 2024
2024-10-01 08:00:44 EST Source
 
 442. COVID19 Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook
2024-10-01 04:43:02 EST Source
 
 443. COVID19 Understanding the rationales and information environments for early, late, and nonadopters of the COVID-19 vaccine
2024-09-29 02:10:43 EST Source
 
 444. COVID19 Altered functional brain connectivity, efficiency, and information flow associated with brain fog after mild to moderate COVID-19 infection
2024-09-28 22:34:30 EST Source
 
 445. COVID19 SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination
2024-09-27 14:45:41 EST Source
 
 446. COVID19 Free test kits
2024-09-26 23:48:26 EST Source
 
 447. COVID19 Louisiana Surgeon General Ralph Abraham blasts state's pandemic response, doubts Covid vaccines
2024-09-26 21:56:01 EST Source
 
 448. COVID19 COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months — COVID-NET, 12 States, October 2022–April 2024
2024-09-26 18:20:30 EST Source
 
 449. COVID19 Long COVID and associated outcomes following COVID-19 reinfections: Insights from an International Patient-Led Survey
2024-09-26 16:01:23 EST Source
 
 450. COVID19 Mechanisms of long COVID and the path toward therapeutics
2024-09-25 20:16:01 EST Source
 
 451. COVID19 The risk factors for long term cardiovascular symptoms in patients after coronavirus disease 2019 infection
2024-09-25 16:13:24 EST Source
 
 452. COVID19 SARS-CoV-2 burden on the floor was associated with COVID-19 cases and outbreaks in two acute care hospitals: a prospective cohort study
2024-09-23 15:32:51 EST Source
 
 453. COVID19 Neural basis of fatigue in post-COVID syndrome and relationships with cognitive complaints and cognition
2024-09-23 11:41:45 EST Source
 
 454. COVID19 Ohio State University Medical Center Quietly Backs Away From COVID Vaccines
2024-09-23 00:18:41 EST Source
 
 455. COVID19 Rapid progression of CD8 and CD4 T cells to cellular exhaustion and senescence during SARS-CoV2 infection
2024-09-22 20:47:33 EST Source
 
 456. COVID19 COVID-19 is a leading cause of death in children and young people in the US
2024-09-21 16:34:40 EST Source
 
 457. COVID19 Genetic Tracing Links SARS-CoV-2 With Animals at Wildlife Market
2024-09-20 06:06:23 EST Source
 
 458. COVID19 Could Timber Help Fight COVID-19 on Surfaces? Scots Pine, Norwegian Spruce, and Oak Show Promising Results!
2024-09-20 01:58:28 EST Source
 
 459. COVID19 How COVID-19 XEC Variant is Impacting Global Health Systems
2024-09-18 05:46:26 EST Source
 
 460. COVID19 COVID-19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England
2024-09-17 19:12:54 EST Source
 
 461. COVID19 SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years
2024-09-16 16:17:15 EST Source
 
 462. COVID19 Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation
2024-09-16 13:10:35 EST Source
 
 463. COVID19 Association of SARS-CoV-2 immunoserology and vaccination status with myocardial infarction severity and outcome
2024-09-15 18:12:34 EST Source
 
 464. COVID19 Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials
2024-09-15 16:15:46 EST Source
 
 465. COVID19 Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
2024-09-10 20:50:26 EST Source
 
 466. COVID19 Verity - Cuomo Testifies Before House COVID Panel
2024-09-10 19:42:47 EST Source
 
 467. COVID19 Testosterone and estradiol reduce inflammation of human macrophages induced by anti-SARS-CoV-2 IgG
2024-09-09 23:05:23 EST Source
 
 468. COVID19 Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
2024-09-09 22:48:32 EST Source
 
 469. COVID19 Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19
2024-09-09 22:34:31 EST Source
 
 470. COVID19 SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis
2024-09-09 22:25:51 EST Source
 
 471. COVID19 Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial
2024-09-09 19:21:33 EST Source
 
 472. COVID19 Impact of COVID-19 pandemic on ocular disease: KNHANES 2015–2021
2024-09-07 06:57:03 EST Source
 
 473. COVID19 Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
2024-09-07 02:36:53 EST Source
 
 474. COVID19 Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
2024-09-06 18:56:48 EST Source
 
 475. COVID19 Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
2024-09-06 01:08:24 EST Source
 
 476. COVID19 Characteristics and predictors of Long Covid in children: a 3-year prospective cohort study
2024-09-05 18:08:30 EST Source
 
 477. COVID19 Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis
2024-09-05 18:06:29 EST Source
 
 478. COVID19 Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis - Nature Communications
2024-09-05 16:24:02 EST Source
 
 479. COVID19 Association of COVID-19 Vaccination with Risk of Medically-Attended Post-Acute Sequelae of COVID-19 During the Ancestral, Alpha, Delta, and Omicron Variant Eras | Open Forum Infectious Diseases
2024-09-05 13:14:38 EST Source
 
 480. COVID19 Zero-covid advocacy during the COVID-19 pandemic: a case study of views on Twitter/X
2024-09-04 16:35:49 EST Source
 

© Copyright hackingthevirus.com 2022-2023 Release Version 1.11162020

Return to top ►

© Copyright hackingai.app 2022-2023 Release Version 1.01202023
Return to top ►